Thein vivoandin vitrometabolism and the detectability in urine of 3’,4’-methylenedioxy-alpha-pyrrolidinobutyrophenone (MDPBP), a new pyrrolidinophenone-type designer drug, studied by GC-MS and LC-MSn

Screening of Stimulants Including Designer Drugs in Urine Using a Liquid Chromatography Tandem Mass Spectrometry System

(2013) P. M. O'Byrne et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Identification of substituted cathinones: 3,4-Methylenedioxy derivatives by high performance liquid chromatography–quadrupole time of flight mass spectrometry

(2013) Emilia Fornal   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

(2013) Ulrich M. Zanger et al.   PHARMACOLOGY & THERAPEUTICS

Prevalence and co-existence of active components of ‘legal highs’

(2012) Dariusz Zuba et al.   Drug Testing and Analysis

New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine

(2012) Markus R. Meyer et al.   JOURNAL OF MASS SPECTROMETRY

The analysis of amphetamine-like cathinone derivatives using positive electrospray ionization with in-source collision-induced dissociation

(2012) John D. Power et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents

(2011) Markus R. Meyer et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept

(2011) Dirk K. Wissenbach et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography–linear ion trap–mass spectrometry (LC-MSn)

(2011) Markus R. Meyer et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Spectroscopic characterization of 3,4-methylenedioxypyrrolidinobutyrophenone: A new designer drug with α-pyrrolidinophenone structure

(2011) Folker Westphal et al.   FORENSIC SCIENCE INTERNATIONAL

Development of the first metabolite-based LC-MS n urine drug screening procedure-exemplified for antidepressants

(2010) Dirk K. Wissenbach et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Automated Mass Spectral Deconvolution and Identification System for GC-MS Screening for Drugs, Poisons, and Metabolites in Urine

(2010) M. R. Meyer et al.   CLINICAL CHEMISTRY

Metabolism of Designer Drugs of Abuse: An Updated Review

(2010) Markus R. Meyer et al.   CURRENT DRUG METABOLISM

Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones

(2010) Simon D. Brandt et al.   Drug Testing and Analysis

Studies on the metabolism of the α-pyrrolidinophenone designer drug methylenedioxy-pyrovalerone (MDPV) in rat and human urine and human liver microsomes using GC-MS and LC-high-resolution MS and its detectability in urine by GC-MS

(2010) Markus R. Meyer et al.   JOURNAL OF MASS SPECTROMETRY

Enantioselectivity in the Methylation of the Catecholic Phase I Metabolites of Methylenedioxy Designer Drugs and Their Capability To Inhibit Catechol-O-methyltransferase-Catalyzed Dopamine 3-Methylation

(2009) Markus R. Meyer et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: A designer drug with α-pyrrolidinophenone structure

(2009) Folker Westphal et al.   FORENSIC SCIENCE INTERNATIONAL

New designer drug α‐pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques

(2009) Christoph Sauer et al.   JOURNAL OF MASS SPECTROMETRY

Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry

(2009) Anika A. Philipp et al.   JOURNAL OF MASS SPECTROMETRY

Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry

(2008) Andreas H. Ewald et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxy-Methamphetamine and Its Enantiomers

(2008) M. R. Meyer et al.   DRUG METABOLISM AND DISPOSITION